Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
External validation of a clinical prediction model for the diagnosis of immune thrombocytopenia
FY 2021-22
Summary
Immune thrombocytopenia (ITP) is an autoimmune disease that results in a low platelet count and increased bleeding risk. Defined simply as a platelet count 100 x 109/L with no known cause, ITP is a diagnosis of exclusion; meaning other causes of low platelets must be ruled out before ITP can be diagnosed. This approach is error-prone and can lead to unnecessary exposures to expensive and harmful treatments. To address this issue, we designed a clinical prediction model, called the Predict-ITP tool, to help clinicians make the ITP diagnosis in the outpatient setting. Mathematical modelling was used to identify four variables that are predictive of the ITP diagnosis and accessible to clinicians at an initial patient encounter: 1) platelet count fluctuation; 2) lowest platelet count level; 3) maximum mean platelet volume; and 4) history of a major bleed. The Predict-ITP tool has been validated internally using data from a single centre. The objective of the current study is to perform an external validation of the Predict-ITP tool by assessing the accuracy of diagnosis in an external patient sample from 10 academic and community hematology clinics over a 10-year period using information available at the initial patient encounter. The gold standard for ITP diagnosis will be the achievement of a platelet count response after high-dose corticosteroids or intravenous immunoglobulin as determined during the follow-up period. Discrimination (ability to differentiate between patients with and without ITP) and calibration (agreement between predicted and actual diagnoses) of the Predict-ITP tool will be determined. The Predict-ITP tool will have an immediate impact for patients and clinicians by reducing delays in diagnosis and avoiding potentially harmful and costly treatments.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466947
Name
Mahamad Syed
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
External validation of a clinical prediction model for the diagnosis of immune thrombocytopenia
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clinical Prediction Model; Clinical Prediction Rule; Clinical Prediction Score; Diagnosis; External Validation; Immune Thrombocytopenia; Platelets
Abstract
Immune thrombocytopenia (ITP) is an autoimmune disease that results in a low platelet count and increased bleeding risk. Defined simply as a platelet count 100 x 109/L with no known cause, ITP is a diagnosis of exclusion; meaning other causes of low platelets must be ruled out before ITP can be diagnosed. This approach is error-prone and can lead to unnecessary exposures to expensive and harmful treatments. To address this issue, we designed a clinical prediction model, called the Predict-ITP tool, to help clinicians make the ITP diagnosis in the outpatient setting. Mathematical modelling was used to identify four variables that are predictive of the ITP diagnosis and accessible to clinicians at an initial patient encounter: 1) platelet count fluctuation; 2) lowest platelet count level; 3) maximum mean platelet volume; and 4) history of a major bleed. The Predict-ITP tool has been validated internally using data from a single centre. The objective of the current study is to perform an external validation of the Predict-ITP tool by assessing the accuracy of diagnosis in an external patient sample from 10 academic and community hematology clinics over a 10-year period using information available at the initial patient encounter. The gold standard for ITP diagnosis will be the achievement of a platelet count response after high-dose corticosteroids or intravenous immunoglobulin as determined during the follow-up period. Discrimination (ability to differentiate between patients with and without ITP) and calibration (agreement between predicted and actual diagnoses) of the Predict-ITP tool will be determined. The Predict-ITP tool will have an immediate impact for patients and clinicians by reducing delays in diagnosis and avoiding potentially harmful and costly treatments.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mahamad, Syed
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~